Published in Drug Law Weekly, October 26th, 2010
Rotlaw will at first focus on providing information about three dangerous consumer products: the acne drug isotretinoin ("Accutane" and generic forms); the contraceptive drospirenone (sold as "Yaz," "Yasmin," and "Ocella"); and the "ASR"-brand replacement hip...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.